AB005. Assessing meaningful changes in disease activity as clinical trial clinical efficacy measures for cutaneous lupus erythematosus

To date, there are no approved treatments for cutaneous lupus erythematosus (CLE), a disease known to significantly burden a patient’s quality of life (QoL). Clinical trials are important for the advancement of treatments and outcome measures of these trials should reflect clinically meaningful impr...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Ann Transl Med
Hauptverfasser: Chakka, Srita, Krain, Rebecca, Ahmed, Sarah, Concha, Josef Symon S., Feng, Rui, Werth, Victoria P.
Format: Artigo
Sprache:Inglês
Veröffentlicht: AME Publishing Company 2021
Schlagworte:
Abstract on Rheumatologic Skin Disease
Online Zugang:https://ncbi.nlm.nih.gov/pmc/articles/PMC8033312/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.21037/atm.2021.AB005
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!

Ähnliche Einträge